Newron Pharmaceuticals S.p.A. (NWPHF)

Newron Pharmaceuticals Revenue

In the year 2024, Newron Pharmaceuticals had annual revenue of 51.39M EUR with 467.41% growth. Newron Pharmaceuticals had revenue of 47.98M in the half year ending December 31, 2024, with 1,370.07% growth.

• Revenue: 51.39M EUR
• Revenue Growth: +467.41%
• P/S Ratio: 4.38
• Revenue / Employee: 2.34M EUR
• Employees: 22
• Market Cap: 232.98M USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	51.39M	42.33M	467.41%
Dec 31, 2023	9.06M	2.96M	48.62%
Dec 31, 2022	6.09M	332.00K	5.76%
Dec 31, 2021	5.76M	504.00K	9.59%
Dec 31, 2020	5.26M	-1.78M	-25.29%